HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Lin Selected Research

transgelin

1/2020TAGLN and High-mobility Group AT-Hook 2 (HMGA2) Complex Regulates TGF-β-induced Colorectal Cancer Metastasis.
1/2020Transgelin interacts with PARP1 in human colon cancer cells.
1/2018Elevated transgelin/TNS1 expression is a potential biomarker in human colorectal cancer.
4/2016AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression.
2/2016Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.
9/2009Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Lin Research Topics

Disease

136Neoplasms (Cancer)
05/2024 - 05/2002
84Breast Neoplasms (Breast Cancer)
04/2024 - 07/2002
39Neoplasm Metastasis (Metastasis)
03/2024 - 01/2004
17Inflammation (Inflammations)
02/2024 - 06/2005
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 12/2002
15Triple Negative Breast Neoplasms
01/2024 - 01/2017
12Infections
05/2023 - 06/2005
11Carcinogenesis
01/2023 - 12/2002
10Lung Neoplasms (Lung Cancer)
12/2023 - 03/2003
9Stomach Neoplasms (Stomach Cancer)
10/2022 - 12/2015
8Alzheimer Disease (Alzheimer's Disease)
03/2024 - 01/2018
8Hypertension (High Blood Pressure)
01/2024 - 08/2011
7Pain (Aches)
05/2024 - 03/2007
7Weight Gain
02/2024 - 10/2012
7Pneumonia (Pneumonitis)
09/2023 - 04/2011
7Carcinoma (Carcinomatosis)
07/2023 - 01/2014
7Cataract (Cataracts)
01/2021 - 02/2008
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 09/2009
6Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 01/2004
6Atherosclerosis
04/2024 - 02/2010
6Myopia
01/2023 - 06/2011
6Body Weight (Weight, Body)
01/2022 - 04/2014
6Hearing Loss (Hearing Impairment)
01/2022 - 01/2011
6Hypoxia (Hypoxemia)
01/2021 - 02/2009
6Insulin Resistance
07/2020 - 08/2002
5Sepsis (Septicemia)
09/2023 - 11/2010
5Adenocarcinoma of Lung
07/2023 - 05/2006
5Hemorrhage
01/2023 - 01/2018
5Thrombosis (Thrombus)
01/2022 - 06/2007
5Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2012
5Leukemia
09/2020 - 03/2013
5Hyperglycemia
10/2019 - 08/2002
4Wounds and Injuries (Trauma)
03/2024 - 08/2014
4Virus Diseases (Viral Diseases)
01/2024 - 01/2018
4Macular Degeneration (Age-Related Maculopathy)
04/2023 - 01/2010
4Gestational Diabetes (Gestational Diabetes Mellitus)
02/2023 - 01/2019
4Fibrosis (Cirrhosis)
01/2023 - 01/2015
4Obesity
10/2022 - 01/2017
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 07/2002
4Disease Progression
06/2022 - 10/2019
4Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 01/2020
4Congenital Abnormalities (Deformity)
03/2022 - 01/2019
4Trisomy (Trisomies)
01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
04/2024 - 05/2002
34Biomarkers (Surrogate Marker)IBA
04/2024 - 02/2003
21CytokinesIBA
03/2024 - 05/2002
16Messenger RNA (mRNA)IBA
02/2024 - 03/2003
15MicroRNAs (MicroRNA)IBA
04/2023 - 03/2009
14Estrogen ReceptorsIBA
09/2021 - 04/2004
13Interleukin-8 (Interleukin 8)IBA
01/2022 - 03/2004
11Interleukin-6 (Interleukin 6)IBA
06/2023 - 08/2008
11Glucose (Dextrose)FDA LinkGeneric
01/2023 - 02/2005
11Retinaldehyde (Retinal)IBA
01/2021 - 01/2010
10EnzymesIBA
03/2024 - 07/2008
10LipidsIBA
02/2024 - 12/2017
8RNA (Ribonucleic Acid)IBA
03/2024 - 12/2017
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 06/2010
8Small Interfering RNA (siRNA)IBA
01/2023 - 04/2012
7CateninsIBA
10/2023 - 04/2015
7Hormones (Hormone)IBA
05/2023 - 01/2006
7Insulin (Novolin)FDA Link
01/2022 - 02/2010
7Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2017 - 01/2012
6Immune Checkpoint InhibitorsIBA
01/2024 - 04/2022
6Histones (Histone)IBA
07/2023 - 01/2017
6osthol (osthole)IBA
11/2022 - 01/2018
6Indicators and Reagents (Reagents)IBA
06/2022 - 01/2017
6transgelinIBA
01/2020 - 09/2009
5LigandsIBA
05/2024 - 03/2004
5AcidsIBA
04/2024 - 01/2014
5Long Noncoding RNAIBA
12/2023 - 01/2015
5AntibodiesIBA
01/2023 - 06/2003
5Docetaxel (Taxotere)FDA Link
01/2023 - 02/2013
5human ERBB2 proteinIBA
12/2022 - 01/2019
5InterferonsIBA
01/2022 - 01/2011
5TamoxifenFDA LinkGeneric
01/2022 - 09/2014
5Transcription Factors (Transcription Factor)IBA
01/2020 - 08/2002
5AntigensIBA
08/2017 - 07/2008
5ORALIT (ORS)IBA
01/2017 - 11/2011
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2012 - 12/2002
4Hydrocortisone (Cortisol)FDA LinkGeneric
04/2024 - 04/2014
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2024 - 01/2018
4Circular RNAIBA
01/2024 - 01/2021
4Capecitabine (Xeloda)FDA Link
01/2024 - 01/2021
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 01/2021
4Cisplatin (Platino)FDA LinkGeneric
07/2023 - 07/2015
4LipopolysaccharidesIBA
01/2023 - 08/2008
4Phosphotransferases (Kinase)IBA
01/2023 - 01/2013

Therapy/Procedure

52Therapeutics
03/2024 - 10/2007
25Drug Therapy (Chemotherapy)
02/2024 - 03/2011
11Immunotherapy
02/2024 - 03/2013
10Neoadjuvant Therapy
04/2024 - 01/2021
6Adjuvant Chemotherapy
01/2024 - 06/2012
6Ligation
01/2023 - 11/2007
5Radiotherapy
04/2024 - 02/2017
5Acupuncture Points (Acupuncture Point)
01/2022 - 02/2010
5Electroacupuncture
01/2021 - 04/2014
4Aftercare (After-Treatment)
10/2022 - 04/2011
4Lasers (Laser)
10/2022 - 08/2010
4Secondary Prevention
05/2022 - 08/2019
4Vitrectomy
01/2022 - 05/2012